DIO2 and cancer: Finally, we demonstrated that the molecular mechanism by which the D2-mediated TH activation fosters cancer progression is the up-regulation of the epithelial–mesenchymal switch of SCC cells through the induction of ZEB1 and repression of E-cadherin [16].